All
Results: 13837-13848 of 71221

Nagarro releases Q3 2025 results with 9.4% YoY revenue growth in constant currency and 27.2% YoY increase in Adjusted EBITDA; announces share redemption and buyback

Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine

Intuit’s All-in-One Platform Introduces a Virtual Team of AI Agents to Help UK Businesses Increase Efficiency and Growth








